Ghidurile ESC - Media Med Publicis

Ghiduri ale Societatii Europene de Cardiologie
medical therapy in the treatment of single-vessel coronary artery
disease. Veterans Affairs ACME Investigators. N Engl J Med
1992;326:10-16.
578. Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary
angioplasty versus medical therapy for stable angina pectoris: outcomes
for patients with double-vessel versus single-vessel coronary artery
disease in a Veterans Affairs Cooperative randomized trial. Veterans
Affairs ACME InvestigatorS. J Am Coll Cardiol 1997;29:1505-1511.
579. RITA-2 trial participants. Coronary angioplasty versus medical therapy
for angina: the second Randomised Intervention Treatment of Angina
(RITA-2) trial participants. Lancet 1997; 350:461-468.
580. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM et al.
Aggressive lipid-lowering therapy compared with angioplasty in stable
coronary artery disease. Atorvastatin versus Revascularization
Treatment Investigators. N Engl J Med 1999;341:70-76.
581. Brophy JM, Belisle P, Joseph L. Evidence for use of coronary stents.
A hierarchical bayesian meta-analysis. Ann Intern Med 2003; 138:
777-786.
582. Al Suwaidi J, Holmes DR Jr, Salam AM, Lennon R, Berger PB. Impact of
coronary artery stents on mortality and nonfatal myocardial infarction:
meta-analysis of randomized trials comparing a strategy of routine
stenting with that of balloon angioplasty. Am Heart J 2004; 147:
815-822.
583. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M
et al. A randomized comparison of a sirolimus-eluting stent with a stan
dard stent for coronary revascularization. N Engl J Med
2002;346:1773-1780.
584. Lansky AJ, Costa RA, Mintz GS, Tsuchiya Y, Midei M, Cox DA et al.
Non-polymer-based paclitaxel-coated coronary stents for the treatment
of patients with de novo coronary lesions: angiographic follow-up of the
DELIVER clinical trial. Circulation 2004;109:1948-1954.
585. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy
С et al. Sirolimus-eluting stents versus standard stents in patients with
stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
586. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JTet al.
A polymer-based, paclitaxel-eluting stent in patients with coronary
artery disease. N Engl J Med 2004; 350:221-231.
587. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C et al.
Guidelines for percutaneous coronary interventions. The Task Force
for Percutaneous Coronary Interventions of the European Society of
Cardiology. Eur Heart J 2005; 26:804-847.
588. Pfisterer ME, Kiowski W, Brunner H, Burckhardt D, Burkart F. Long-term
benefit of 1-year amiodarone treatment for persistent complex ventri
cular arrhythmias after myocardial infarction. Circulation 1993;87:
309-311.
589. Hueb WA, Bellotti G, de Oliveira SA, Arie S, de Albuquerque CP, Jatene
AD et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospec
tive, randomized trial of medical therapy, balloon angioplasty or bypass
surgery for single proximal left anterior descending artery stenoses. J
Am Coll Cardiol 1995;26:1600-1605.
587. The Bypass Angioplasty Revascularization Investigation (BARI)
Investigators. Comparison of coronary bypass surgery with angioplasty
in patients with multivessel disease. N Engl J Med 1996;335:217-225.
588. King SB III, LemboNJ,WeintraubWS, KosinskiAS, BarnhartHX, KutnerMH
et al. A randomized trial comparing coronary angioplasty with coronary
bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J
Med1994;331:1044-1050.
589. Coronary angioplasty versus coronary artery bypass surgery: the
Randomized Intervention Treatment of Angina (RITA) trial. Lancet
1993;341:573-580.
590. Henderson RA, Pocock SJ, Sharp SJ, Nanchahal K, Sculpher MJ, Buxton MJ
et al. Long-term results of RITA-1 trial: clinical and cost comparisons
of coronary angioplasty and coronary-artery bypass grafting.
Randomised Intervention Treatment of Angina. Lancet 1998;352:
1419-1425.
591. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MI, Palacios
IF. Argentine randomized trial of percutaneous transluminal coronary
angioplasty versus coronary artery bypass surgery in multivessel
disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
J Am Coll Cardiol 1993;22:1060-1067.
592. Rodriguez A, Mele E, Peyregne E, Bullon F, Perez-Balino N, Liprandi MI
et al. 3 year follow-up of the Argentine Randomized Trial of
Percutaneous Transluminal Coronary Angioplasty versus Coronary
Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll
Cardiol 1996;27:1178-1184.
593. CABRI Trial Participants. First-year results of CABRI (Coronary
Angioplasty versus Bypass Revascularisation Investigation). Lancet
1995;346:1179-1184.
594. SoS Investigators. Coronary artery bypass surgery versus percutaneous
coronary intervention with stent implantation in patients with multives
sel coronary artery disease (the Stent or Surgery trial): a randomised
controlled trial. Lancet 2002;360:965-970.
595. Goy JJ, Kaufmann U, Goy-Eggenberger D, Garachemani A, Hurni M,
Carrel T et al. A prospective randomized trial comparing stenting to
internal mammary artery grafting for proximal, isolated de novo left
anterior coronary artery stenosis: the SIMA trial. Stenting vs. Internal
Mammary Artery. Mayo Clin Proc 2000;75:1116-1123.
596. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB III, Hamm
CW et al. Meta-analysis of randomised trials comparing coronary angio
plasty with bypass surgery. Lancet 1995;346:1184-1189.
597. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP
et al. Comparison of coronary-artery bypass surgery and stenting for
the treatment of multivessel disease. N Engl J Med
2001;344:1117-1124.
598. Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH
et al. 1 year outcomes of coronary artery bypass graft surgery versus
percutaneous coronary intervention with multiple stenting for multisys
tem disease: a meta-analysis of individual patient data from randomized
clinical trials. J Thorac Cardiovasc Surg 2005;130:512-519.
599. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E et al.
Long-term outcomes of coronary-artery bypass grafting versus stent
implantation. N Engl J Med 2005;352:2174-2183.
600. Joyce D, Loebe M, Noon GP, McRee S, Southard R, Thompson L et al.
Revascularization and ventricular restoration in patients with ischaemic
heart failure: the STICH trial. Curr Opin Cardiol 2003; 18:454-457.
601. Cleland JG, Freemantle N, Ball SG, Bonser RS, Camici P, Chattopadhyay S
et al. The heart failure revascularisation trial (HEART): rationale, design
and methodology. Eur J Heart Fail 2003;5:295-303.
602. Silvestri M, Barragan P, Sainsous J, Bayet G, Simeoni JB, Roquebert PO
et al. Unprotected left main coronary artery stenting: immediate and
medium-term outcomes of 140 elective procedures. J Am Coll Cardiol
2000;35:1543-1550.
606. Black A, Cortina R, Bossi I, Choussat R, Fajadet J, Marco J. Unprotected
left main coronary artery stenting: correlates of midterm survival and
impact of patient selection. J Am Coll Cardiol 2001;37:832-838.
607. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK et al.
Sirolimus-eluting stent implantation for unprotected left main coronary
artery stenosis: comparison with bare metal stent implantation. J Am
Coll Cardiol 2005;45:351-356.
608. Flaherty JD, Davidson CJ. Diabetes and coronary revascularization.
JAMA 2005;293:1501-1508.
609. Brooks RC, Detre KM. Clinical trials of revascularization therapy in dia
betics. Curr Opin Cardiol 2000; 15:287-292.
610. 7 year outcome in the Bypass Angioplasty Revascularization
Investigation (BARI) by treatment and diabetic status. J Am Coll
Cardiol 2000;35:1122-1129.
611. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E
et al. Sirolimus-eluting stents for treatment of patients with long ather
osclerotic lesions in small coronary arteries: double-blind, randomised
controlled trial (E-SIRIUS). Lancet 2003;362:1093-1099.
612. Lytle BW, Loop FD, Taylor PC, Simpfendorfer C, Kramer JR, Ratliff NB
et al. Vein graft disease: the clinical impact of stenoses in saphenous
vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg
1992;103:831-840.
613. Lytle BW, Loop FD, Taylor PC, Goormastic M, Stewart RW, Novoa R et al.
The effect of coronary reoperation on the survival of patients with
stenoses in saphenous vein bypass grafts to coronary arteries. J
Thorac Cardiovasc Surg 1993;105:605-612; discussion 612-614.
614. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ et al.
ACC/AHA 2004 guideline update for coronary artery bypass graft
surgery: summary article. A report of the American College of
Cardiology/American Heart Association Task Force on Practice
Guidelines (Committee to Update the 1999 Guidelines for Coronary
Artery Bypass Graft Surgery). J Am Coll Cardiol 2004;44:
1146-54-1213-310.
615. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE et al.
Randomized trial of a distal embolic protection device during percuta
neous intervention of saphenous vein aorto-coronary bypass grafts.
Circulation 2002; 105:1285-1290.
616. Sirnes PA, Golf S, Myreng Y, Molstad P, Emanuelsson H, Albertsson P et al.
Stenting in Chronic Coronary Occlusion (SICCO): a randomized, con
trolled trial of adding stent implantation after successful angioplasty.
J Am Coll Cardiol 1996; 28:1444-1451.
64